The dietary supplement ephedrine induces β-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 mice

Lupus

Volumn 14, Issue 4, 2005, Pages 293-307

  Hudson, C A ^a   Mondal, T K ^a   Cao, L ^a   Kasten Jolly, J ^a   Huber, V C ^a   Lawrence, David A ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

B1 cells; Beta adrenergic; CD40; CD5+B cells; Ephedrine; NZM strains

Indexed keywords

AUTOANTIBODY; CD5 ANTIGEN; DNA ANTIBODY; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; EPHEDRINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; ISOPRENALINE; PROPRANOLOL; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE EXACERBATION; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; LIFESPAN; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-OBESITY AGENTS; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; DIETARY SUPPLEMENTS; EPHEDRINE; FEMALE; IMMUNOGLOBULIN G; LONGEVITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED BALB C; PLASMA CELLS; PROPRANOLOL; T-LYMPHOCYTE SUBSETS;

EID: 17644383025     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2078oa     Document Type: Article

References (53)

1. Malecka-Tendera E. Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoprotein lipase activity in obese over-fed rats. Int J Obes Relat Metab Disord 1993; 17: 343-347.
2. Molnar D, Torok K, Erhardt E, Jeges S. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo controlled pilot study in adolescents. Int J Obes Relat Meta. Disord 2000; 24: 1573-1578.
3. Bell DG, Jacobs I, Ellerington K. Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc 2001; 33: 1399-1403.
4. Samenuk D, Link MS, Homoud MK et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002; 77: 12-16.
5. Fairchild MD, Alles GA. The central locomotor activity and acute toxicity of the ephedrine and norephedrine isomers in mice. J Pharmacol Exp Ther 1967; 158: 135-139.
6. Drug Facts and Comparisons. 2001 annual EFacts CD-Rom St. Louis, MO: Facts and Comparison, Inc.
7. Ephedrine: Fast Facts Do It Now Foundation. 2002. www.doitnow.org (last accessed 25 November 2004).
8. Gluck T, Oertel M, Reber T, Zietz B, Scholmerich J, Straub RH. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. 1. The hypothalamus-autonomic nervous system axis. J Rheumatol 2000; 27: 903-910.
9. Shanks N, Moore PM, Perks P, Lightman SL. Alterations in hypothalamic pituitary-adrenal function correlated with the onset of murine SLE in MRL +/+ and lpr/lpr. Brain Behav Immun 1999; 13: 348-360.
10. Pettinger WA, Mitchell HC. Side effects of vasodilator therapy. Hypertension 1988; 11: 34-36.
11. McGuiness M, Frye RA, Deng JS. Atenelol-induced lupus erythematosus. J Am Acad Dermatol 1997; 37: 298-299.
12. Herrmann M, Scholmerich J, Straub RH. Stress and rheumatic diseases. Rheum Dis Clin North Am 2000; 26: 737-763.
13. Colburn K, Boucek R, Gusewitch G, Wong A, Wat P, Weeks D. Beta-adrenergic receptor stimulation increases anti-DNA antibody production in MRL/lpr mice. J Rheumatol 1990; 17: 138-141.
14. + T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 2001; 53: 487-525.
15. Gage JR, Fonarow G, Hamilton M, Widawski M, Martinez-Maza O, Vredevoe DL. Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure. Neuroimmunomodulation 2004; 11: 173-180.
16. Hudson CA, Cao L, Kasten-Jolly J, Kirkwood JN, Lawrence DA. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J Toxicol Environ Health A 2003; 66: 895-918.
17. Heo Y, Lee WT, Lawrence DA. Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes. Toxicol Sci 1998; 43: 172-185.
18. Morimoto I. A study on immunological effects of L-canavanine. Kobe J Med Sci 1989; 35: 287-298.
19. Takemura H, Hatta S, Yamada K, Ohshika H. Beta-adrenergic receptor-mediated calcium mobilization in the human Jurkat T cell line. Life Sci 1995; 56: 1443-1454.
20. Malinow MR, Bardana EJ, Jr, Pirofsky B, Craig S, McLaughlin P. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 1982; 216: 415-417.
21. Fajka-Boja R, Hidvegi M, Shoenfeld Y et al. Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class I proteins in tumor T and B cell lines. Int J Oncol 2002; 20: 563-570.
22. Ehrenfeld M, Blank M, Schoenfeld Y, Hidvegi M. AVEMAR (a new benzoquine-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease. Lupus 2001; 10: 622-627.
23. Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol 2001; 96: 1654-1655.
24. Youssef WI, Tavill AS. Connective tissue diseases and the liver. J Clin Gastroenterol 2002; 35: 345-349.
25. Wooten MR, Khangure MS, Murphy MJ. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Ann Neurol 1983; 13: 337-340.
26. Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest 1993; 68: 419-426.
27. Mohan C, Morel L, Yang P et al. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest 1999; 103: 1685-1695.
28. Mohan C, Morel L, Yang P, Wakeland EK. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol 1997; 159: 454-465.
29. Mohan C, Morel L, Yang P, Wakeland EK. Accumulation of splenic Bla cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum 1998; 41: 1652-1662.
30. Rudofsky UH, Lawrence DA. New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. Environ Health Perspect 1999; 107: 713-721.
31. Heo Y, Lee WT, Lawrence DA. In vivo the environmental pollutants lead and mercury induce oligoclonal T cell responses skewed toward type-2 reactivities. Cell Immunol 1997; 179: 185-195.
32. Lawrence DA. In vivo and in vitro effects of lead on humoral and cell mediated immunity. Infect Immun 1981; 31: 136-143.
33. Harada Y, Kawano MM, Huang N et al. Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 1996; 92: 184-191.
34. Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. Eur J Immunol 2001; 31: 2726-2732.
35. Youinou P, Mackenzie LE, Lamour A, Mageed RA, Lydyard PM. Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases. Eur J Clin Invest 1993; 23: 139-150.
36. Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again:ephedrine nephrolithiasis. Am J Kidney Dis 1998; 32: 153-159.
37. Kimberly RP, Gill JR Jr, Bowden RE, Keiser HR, Plotz PH. Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus. Ann Intern Med 1978; 89: 336-341.
38. Hayashi T, Hasegawa K, Ohta A, Maeda K. Reduction of serum interferon (IFN) gamma concentration and lupus development in NZB x NZWF(1)mice by lactic dehydrogenase virus infection. J Comp Pathol 2001; 125: 285-291.
39. Sanmarti R, Collado A, Gratacos J et al. Reduced serum creatine kinase activity in inflammatory rheumatic diseases. J Rheumatol 1996; 23: 310-312.
40. Lee YH, Choi SJ, Ji JD, Song GG. Serum creatine kinase in patients with rheumatic diseases. Clin Rheumatol 2000; 19: 296-300.
41. Heo Y, Parson PJ, Lawrence DA. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol 1996; 138: 149-157.
42. Kotzin BL, Kozora E. Anti-DNA meets NMDA in neuropsychiatric lupus. Nat Med 2001; 7: 1175-1176.
43. Kowal C, DeGiorgio LA, Nakaoka T et al. Cognition and immunity: antibody impairs memory. Immunity 2004; 21: 179-188.
44. Cassese, G., Lindenau S, de Boer B et al. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Euro J Immunol 2001; 120: 10-18.
45. Rudick RA, Eskin TA. Neuropathological features of a lupus-like disorder in autoimmune mice. Ann Neurol 1983; 14: 325-332.
46. Kaneko Y, Hirose S, Abe M, Yagita H, Okumura K, Shirai T. CD40 mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus. Eur J Immunol 1996; 26: 3061-3065.
47. Raman C. CD5, an important regulator of lymphocyte selection and immune tolerance. Immunol Res 2002; 26: 255-263.
48. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5: 337-343.
49. Cao L, Hudson CA, Lawrence DA. Acute cold/restraint stress inhibits host resistance to Listeria monocytogenes via beta1-adrenergic receptors. Brain Behav Immun 2003; 17: 121-133.
50. Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc 2003; 24: 79-83.
51. Wozniacka A, Sysa-Jedrzejowska A, Robak E, Samochocki Z, Zak-Prelich M. Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients. Mediators Inflamm 2003; 12: 95-99.
52. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation induced immunosuppression. Nature 1988; 394: 897-901.
53. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 2002; 21: 471-495.